M Fisher, W Schaebitz - Archives of internal medicine, 2000 - jamanetwork.com
The effort to develop effective therapies for acute ischemic stroke achieved several im- portant successes during the past decade, but also many disappointing failures. The 2 …
J Kessler, A Thiel, H Karbe, WD Heiss - Stroke, 2000 - Am Heart Assoc
Background and Purpose—In a prospective, double-blind, placebo-controlled study, it was investigated whether piracetam improves language recovery in poststroke aphasia …
AE Hillis, J Heidler - Aphasiology, 2002 - Taylor & Francis
Background: The course of recovery of aphasia after stroke is highly variable. Some patients, even with severe aphasia, recover rapidly over the first days after onset. The …
U Keil, I Scherping, S Hauptmann… - British journal of …, 2006 - Wiley Online Library
Mitochondrial dysfunction including decrease of mitochondrial membrane potential and reduced ATP production represents a common final pathway of many conditions associated …
Ischemia is localized tissue anemia due to obstruction of the inflow of arterial blood, thus brain ischemia is the condition where insufficient blood is delivered to the brain. Many …
Together, thousands of neurons with similar function make up topographically oriented sensory cortex maps that represent contralateral body parts. Although this is an accepted …
B Gabryel, M Adamek, A Pudełko, A Małecki… - Neurotoxicology, 2002 - Elsevier
The aim of the present study was to establish whether piracetam (2-pyrrolidon-N-acetamide; PIR) and vinpocetine (a vasoactive vinca alkaloid; VINP) are capable of protecting …
K Leuner, C Kurz, G Guidetti, JM Orgogozo… - Frontiers in …, 2010 - frontiersin.org
Piracetam, the prototype of the so-called nootropic drugs' is used since many years in different countries to treat cognitive impairment in aging and dementia. Findings that …
A Piazzini, R Chifari, MP Canevini, K Turner… - Epilepsy research, 2006 - Elsevier
PURPOSE: The aim of the present study is to verify whether patients with partial epilepsy receiving levetiracetam (LEV) as an add-on treatment show an improvement in cognitive …